26 May 2026

strategyland.uk

Marks and Spencer Group PLC (MKS)

Rank #14 of 100 - Consumer Non-Cyclicals - UK Equities

Home/Stocks/Consumer Non-Cyclicals

Marks and Spencer Group PLC

MKS.L·Consumer Non-Cyclicals·Market Cap £7.2b

Rank #14 of 100

Data from Excel Model · 100 Stocks Analysed

£3.43

+5.61% YTD

Target: £4.29(+25.0%)

52W: £3.01 - £4.12

Score Analysis

Marks and Spencer Group PLC is ranked #14 out of 100 UK stocks. Lower factor scores indicate better performance in that category.

Factor Breakdown

39/100

Average Score

Liquidity

Weak61/100

Valuation

Good31/100

Profitability

Excellent12/100

Solvency

Weak82/100

Asset Efficiency

Excellent3/100

Mkt Trading

Fair48/100

Technical

Good37/100

1. Valuation

Score: 31/100

Is MKS undervalued compared to its peers and fair value metrics?

4/5

valuation criteria met

✓

FY26e P/E Ratio

10.8xRank 22/100

✓

FY27e P/E Ratio

9.9xRank 20/100

✗

Price-to-Book

2.20xRank 47/100

✓

Price-to-Tangible Book

2.93xRank 39/100

✓

EV/EBITDA

6.1xRank 19/100

Key Valuation Metrics

Current P/E

372.7x

Price-to-Earnings

FY26e P/E

10.8x

Forward estimate

FY27e P/E

9.9x

Forward estimate

P/B Ratio

2.20x

Price-to-Book

P/TBV

2.93x

Price-to-Tangible Book

EV/EBITDA

6.1x

Enterprise Value

FY26e EV/EBITDA

5.7x

Forward estimate

FY27e EV/EBITDA

5.7x

Forward estimate

Analyst Consensus Target

Current Price

£3.43

Consensus Target

£4.29

Potential

+25.0%

Target

Bloomberg Median Target: £4.38

2. Profitability

Score: 12/100

How profitable is MKS relative to its peers?

2/6

profitability criteria met

✓

TTM Profit Margin

1.4%Rank 11/100

–

Current ROE

8.7%

–

Current ROA

N/A

✓

FY26e EPS

0.36Rank 20/100

–

TTM EPS

0.33

–

Net Income Growth

N/A

Profit Margin

1.4%

ROE

8.7%

FY27e ROE

18.7%

ROA

N/A

Earnings Per Share

3. Financial Health

Score: 82/100

How strong is MKS's balance sheet and financial position?

0/4

solvency criteria met

–

Debt-to-Equity

106.1%

–

Interest Coverage

N/A

✗

Debt/EBITDA

Rank 54Rank 54/100

–

Altman Z-Score

2.93

Key Health Metrics

Quick Ratio

0.54

Below 1.0

Cash Ratio

0.86

Debt/Equity

106%

FCF Margin

0.2%

Altman Z-Score

2.93

Grey Zone

01.812.995+

4. Asset Efficiency

Score: 3/100

How efficiently does MKS deploy its assets and intellectual capital?

0/2

asset efficiency criteria met

–

Intangible/Asset

Intangible assets as a proportion of total assets — lower indicates more tangible, capital-efficient operations

N/A

–

R&D/Sales

Research & development spend relative to revenue — balanced R&D investment signals sustainable growth

N/A

Overall Asset Efficiency Rank

Rank within sector peers#3/100

Best (1)Worst (100)

What This Measures

Intangible/Asset — a lower ratio suggests the company's value is backed by tangible assets rather than goodwill or intangibles, reducing balance sheet risk.

R&D/Sales — captures the proportion of revenue reinvested into research and development, indicating innovation intensity and future growth investment.